FDA And Nuwellis Address Potentially High-Risk Issue With Blood Circuit Device
Nuwellis Regains Compliance With Nasdaq Listing Requirements
On December 11, 2024, Nuwellis Sent A Notice To Affected Customers That It Is Voluntarily Recalling Specific Lots Of AquaFlexFlow UF 500 Plus Extracorporeal Blood Circuit Which Is Used With The Aquadex Smartflow Or Aquadex Flexflow System - Filing
Express News | Nuwellis Inc - Aware of 5 Reported Incidents of Blood Circuit Failures, Three Leading to Dehydration
Express News | Nuwellis Inc - Announces Voluntary Recall of Specific Lots of Aquaflexflow Uf 500 Plus Extracorporeal Blood Circuit
Nuwellis Files for Secondary Stock Offering
Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating
10-Q: Q3 2024 Earnings Report
8-K: Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript Summary
Nuwellis Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Revenue Results.
RAPT Therapeutics RAPT Program Terminated; Nuwellis NUWE Earnings
Nuwellis GAAP EPS of $1.74 Beats by $3.02, Revenue of $2.34M Misses by $0.06M
Express News | Nuwellis Inc: Got Notice of 297% Rise to $1,639 per Day in Reimbursement From CMS
Nuwellis 3Q EPS $1.74 >NUWE
Earnings Flash (NUWE) NUWELLIS Reports Q3 Revenue $2.4M
Express News | Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
Press Release: Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
Earnings Scheduled For November 11, 2024